Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.
Press releases published on September 8, 2025
September 8, 2025
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
Indeterminate
GlobeNewswire
September 8, 2025
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
Indeterminate
GlobeNewswire
September 8, 2025
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
Indeterminate
GlobeNewswire
September 8, 2025
PharmAla Completes Import of LaNeo MDMA for US Distribution
Indeterminate
GlobeNewswire
September 8, 2025
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
Indeterminate
GlobeNewswire
September 8, 2025
Rapport Announces Proposed Public Offering of Common Stock
Indeterminate
GlobeNewswire
September 8, 2025
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
Indeterminate
GlobeNewswire
September 8, 2025
Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)
Indeterminate
GlobeNewswire
September 8, 2025
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
Indeterminate
GlobeNewswire
September 8, 2025
Tren Cycle for Bodybuilding: CrazyBulk Introduce Test and Tren Stack for Muscle Growth, Dosage, Benefits & Results
Indeterminate
GlobeNewswire
September 8, 2025
Shiny Smile Veneers Surpasses 100,000 Smiles Transformed in 2025 as Demand for Lifestyle Dental Health Solutions Grows
Indeterminate
GlobeNewswire
September 8, 2025
WellSpan ACO earns high performance, savings under Medicare Shared Savings Program
Indeterminate
GlobeNewswire
September 8, 2025
DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight
Indeterminate
GlobeNewswire
September 8, 2025
Press Release : Sequana Medical Announces New Share Capital Amount and New Number of Shares
Indeterminate
GlobeNewswire
September 8, 2025
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
Indeterminate
GlobeNewswire